Vaxxinity (NASDAQ:VAXX) Now Covered by Robert W. Baird

Stock analysts at Robert W. Baird initiated coverage on shares of Vaxxinity (NASDAQ:VAXX – Get Free Report) in a research report issued to clients and investors on Thursday, FlyOnTheWall reports. The brokerage set an “outperform” rating and a $7.00 price target on the stock. Robert W. Baird’s price objective points to a potential upside of […]

Related Keywords

United States ,Robertw Baird , ,Blackrock Inc ,Vaxxinity Inc ,Susquehanna International Group ,Vanguard Group Inc ,Vaxxinity Company Profile ,Geode Capital Management ,Get Free Report ,Street Corp ,Capital Management ,Vaxxinity Daily ,Vaxxinity ,Nasdaq Vaxx ,Vaxx ,Medical ,Initiated Coverage ,